These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 12035820)

  • 1. Therapeutic drug monitoring in HIV infection: current status and future directions.
    Back D; Gatti G; Fletcher C; Garaffo R; Haubrich R; Hoetelmans R; Kurowski M; Luber A; Merry C; Perno CF
    AIDS; 2002 Mar; 16 Suppl 1():S5-37. PubMed ID: 12035820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic drug monitoring and drug-drug interactions involving antiretroviral drugs.
    Boffito M; Acosta E; Burger D; Fletcher CV; Flexner C; Garaffo R; Gatti G; Kurowski M; Perno CF; Peytavin G; Regazzi M; Back D
    Antivir Ther; 2005; 10(4):469-77. PubMed ID: 16038472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status and future prospects of therapeutic drug monitoring and applied clinical pharmacology in antiretroviral therapy.
    Boffito M; Acosta E; Burger D; Fletcher CV; Flexner C; Garaffo R; Gatti G; Kurowski M; Perno CF; Peytavin G; Regazzi M; Back D
    Antivir Ther; 2005; 10(3):375-92. PubMed ID: 15918329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic drug monitoring in the treatment of HIV-infection.
    Gerber JG; Acosta EP
    J Clin Virol; 2003 Jul; 27(2):117-28. PubMed ID: 12829033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical benefit of interventions driven by therapeutic drug monitoring.
    Rendón A; Núñez M; Jiménez-Nácher I; González de Requena D; González-Lahoz J; Soriano V
    HIV Med; 2005 Sep; 6(5):360-5. PubMed ID: 16156885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low rate of virological failure and maintenance of susceptibility to HIV-1 protease inhibitors with first-line lopinavir/ritonavir-based antiretroviral treatment in clinical practice.
    Prosperi MC; Zazzi M; Punzi G; Monno L; Colao G; Corsi P; Di Giambenedetto S; Meini G; Ghisetti V; Bonora S; Pecorari M; Gismondo MR; Bagnarelli P; Carli T; De Luca A;
    J Med Virol; 2010 Dec; 82(12):1996-2003. PubMed ID: 20981785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits and Limits of Antiretroviral Drug Monitoring in Routine Practice.
    Maitre T; Muret P; Blot M; Waldner A; Duong M; Si-Mohammed A; Chavanet P; Aho S; Piroth L
    Curr HIV Res; 2019; 17(3):190-197. PubMed ID: 31490758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.
    Hirsch MS; Conway B; D'Aquila RT; Johnson VA; Brun-Vézinet F; Clotet B; Demeter LM; Hammer SM; Jacobsen DM; Kuritzkes DR; Loveday C; Mellors JW; Vella S; Richman DD
    JAMA; 1998 Jun; 279(24):1984-91. PubMed ID: 9643863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of antiretroviral therapy.
    Di Perri G; Sinicco A; Audagnotto S; Gobbi F; Canta F; Marrone R; Bonora S
    New Microbiol; 2004 Apr; 27(2 Suppl 1):131-4. PubMed ID: 15646076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amprenavir or fosamprenavir plus ritonavir in HIV infection: pharmacology, efficacy and tolerability profile.
    Arvieux C; Tribut O
    Drugs; 2005; 65(5):633-59. PubMed ID: 15748098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic drug monitoring of antiretroviral drugs in HIV-infected patients.
    Punyawudho B; Singkham N; Thammajaruk N; Dalodom T; Kerr SJ; Burger DM; Ruxrungtham K
    Expert Rev Clin Pharmacol; 2016 Dec; 9(12):1583-1595. PubMed ID: 27626677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of initial antiretroviral therapy based on lopinavir/ritonavir plus 2 nucleoside/nucleotide analogs in patients with human immunodeficiency virus type 1 infection].
    Zamora L; Gatell JM
    Enferm Infecc Microbiol Clin; 2014 Nov; 32 Suppl 3():2-6. PubMed ID: 25542868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The advantages of therapeutic drug monitoring in patients receiving antiretroviral treatment and experiencing medication-related problems.
    Schoenenberger JA; Aragones AM; Cano SM; Puig T; Castello A; Gomez-Arbones X; Porcel JM
    Ther Drug Monit; 2013 Feb; 35(1):71-7. PubMed ID: 23188184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic drug monitoring: an aid to optimising response to antiretroviral drugs?
    Aarnoutse RE; Schapiro JM; Boucher CA; Hekster YA; Burger DM
    Drugs; 2003; 63(8):741-53. PubMed ID: 12662123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic drug monitoring and the inhibitory quotient of antiretroviral drugs: can they be applied to the current situation?
    Ribera E; López-Cortés LF; Soriano V; Casado JL; Mallolas J
    Enferm Infecc Microbiol Clin; 2005 Jul; 23 Suppl 2():41-67. PubMed ID: 16373004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.
    Yeni PG; Hammer SM; Carpenter CC; Cooper DA; Fischl MA; Gatell JM; Gazzard BG; Hirsch MS; Jacobsen DM; Katzenstein DA; Montaner JS; Richman DD; Saag MS; Schechter M; Schooley RT; Thompson MA; Vella S; Volberding PA
    JAMA; 2002 Jul; 288(2):222-35. PubMed ID: 12095387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic drug monitoring of antiretroviral agents.
    Bean P; Patnaik M; Graziano FM; Aziz DC
    Am Clin Lab; 2000 May; 19(4):20-2. PubMed ID: 10947316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 drug resistance and associated factors among adults failing first-line highly active antiretroviral therapy in Ho Chi Minh City, Vietnam.
    Pham QD; Huynh TK; Luong TT; Tran T; Vu TX; Truong LX
    HIV Clin Trials; 2013; 14(1):34-44. PubMed ID: 23372113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.